Literature DB >> 6609709

Pregnancy-specific beta 1-glycoprotein (SP1) in serum and tissue from patients with benign and malignant breast tumours.

S Sørensen, J Andersen, T Nørgaard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6609709      PMCID： PMC1976724          DOI： 10.1038/bjc.1984.103

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  13 in total

1.  Radioimmunoassay of "pregnancy-specific"-beta 1-glycoprotein (SP1).

Authors:  J Kaminska; I Calvert; S W Rosen
Journal:  Clin Chem       Date:  1979-04       Impact factor: 8.327

2.  Purification of the major component of the pregnancy-specific beta 1-glycoprotein (SP1) by affinity chromatography, and application to a highly sensitive radioimmunoassay.

Authors:  S Sørensen; S Trentemøller
Journal:  Oncodev Biol Med       Date:  1983

3.  Organisation of the Danish adjuvant trials in breast cancer.

Authors:  K W Andersen; H T Mouridsen; T Castberg; K Fischerman; J Andersen; K Hou-Jensen; H Brincker; H Johansen; E Henriksen; M Rørth; N Rossing
Journal:  Dan Med Bull       Date:  1981-08

4.  Prognostic significance of inappropriate production of pregnancy proteins by breast cancers.

Authors:  C H Horne; I N Reid; G D Milne
Journal:  Lancet       Date:  1976-08-07       Impact factor: 79.321

5.  Ectopic synthesis of pregnancy specific beta 1-glycoprotein (SP1) and placental specific tissue proteins (PP5, PP10, PP11, PP12) in nontrophoblastic malignant tumours. Possible markers in oncology.

Authors:  N Inaba; T Renk; K Wurster; W Rapp; H Bohn
Journal:  Klin Wochenschr       Date:  1980-08-01

6.  Reduction of non-specific serum responses in human pituitary gonadotrophin radioimmunoassays.

Authors:  W M Hunter; J G Bennie
Journal:  J Endocrinol       Date:  1979-01       Impact factor: 4.286

7.  Circulating levels of pregnancy specific beta 1 glycopretein in patients with testicular, bronchogenic and breast carcinomas.

Authors:  J G Grudzinskas; R C Coombes; J G Ratcliffe; Y B Gordon; T J Powles; A M Neville; T Chard
Journal:  Cancer       Date:  1980-01-01       Impact factor: 6.860

8.  Serum concentrations of SP1 (pregnancy-specific-beta1-glycoprotein) in healthy, nonpregnant individuals, and in patients with nontrophoblastic malignant neoplasms.

Authors:  H Würz
Journal:  Arch Gynecol       Date:  1979-03-28

9.  Serum-SP1-pregnancy-specific-beta-glycoprotein in choriocarcinoma and other neoplastic disease.

Authors:  F Searle; B A Leake; K D Bagshawe; J Dent
Journal:  Lancet       Date:  1978-03-18       Impact factor: 79.321

10.  The diagnostic value of circulating trophoblast-specific beta 1-glycoprotein (TSG) in cancer patients.

Authors:  Y S Tatarinov
Journal:  Br J Cancer       Date:  1980-05       Impact factor: 7.640
View more
  2 in total

1.  Pregnancy Specific β-1 Glycoprotein 1 is Expressed in Pancreatic Ductal Adenocarcinoma and its Subcellular Localization Correlates with Overall Survival.

Authors:  Jasmin H Shahinian; Hannah Fuellgraf; Stefan Tholen; Justin Mastroianni; Julia Daniela Knopf; Markus Kuehs; Bettina Mayer; Manuel Schlimpert; Birte Kulemann; Simon Kuesters; Jens Hoeppner; Ulrich F Wellner; Martin Werner; Ulrich T Hopt; Robert Zeiser; Peter Bronsert; Oliver Schilling
Journal:  J Cancer       Date:  2016-10-17       Impact factor: 4.207

2.  Krüppel-Like Factor 10 participates in cervical cancer immunoediting through transcriptional regulation of Pregnancy-Specific Beta-1 Glycoproteins.

Authors:  Daniel Marrero-Rodríguez; Keiko Taniguchi-Ponciano; Malayannan Subramaniam; John R Hawse; Kevin S Pitel; Hugo Arreola-De la Cruz; Victor Huerta-Padilla; Gustavo Ponce-Navarrete; Ma Del Pilar Figueroa-Corona; Laura Gomez-Virgilio; Teresa I Martinez-Cuevas; Monica Mendoza-Rodriguez; Miriam Rodriguez-Esquivel; Pablo Romero-Morelos; Jorge Ramirez-Salcedo; Michael Baudis; Marco Meraz-Rios; Florinda Jimenez-Vega; Mauricio Salcedo
Journal:  Sci Rep       Date:  2018-06-21       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.